Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer.
Publication
, Other
Aziz, H; Marcom, PK; Hwang, ES
Published in: Ann Surg Oncol
May 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
May 2015
Volume
22
Issue
5
Start / End Page
1404 / 1405
Location
United States
Related Subject Headings
- Receptor, erbB-2
- Receptor, ErbB-2
- Oncology & Carcinogenesis
- Molecular Targeted Therapy
- Humans
- Female
- Breast Neoplasms
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Aziz, H., Marcom, P. K., & Hwang, E. S. (2015). Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer. Ann Surg Oncol. United States. https://doi.org/10.1245/s10434-015-4503-6
Aziz, Hamza, P Kelly Marcom, and E Shelley Hwang. “Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer.” Ann Surg Oncol, May 2015. https://doi.org/10.1245/s10434-015-4503-6.
Aziz H, Marcom PK, Hwang ES. Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer. Vol. 22, Ann Surg Oncol. 2015. p. 1404–5.
Aziz, Hamza, et al. “Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer.” Ann Surg Oncol, vol. 22, no. 5, May 2015, pp. 1404–05. Pubmed, doi:10.1245/s10434-015-4503-6.
Aziz H, Marcom PK, Hwang ES. Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer. Ann Surg Oncol. 2015. p. 1404–1405.
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
May 2015
Volume
22
Issue
5
Start / End Page
1404 / 1405
Location
United States
Related Subject Headings
- Receptor, erbB-2
- Receptor, ErbB-2
- Oncology & Carcinogenesis
- Molecular Targeted Therapy
- Humans
- Female
- Breast Neoplasms
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis